Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 380809, 9 pages
http://dx.doi.org/10.1093/ecam/neq079
Review Article

Dilong: Role in Peripheral Nerve Regeneration

1School of Chinese Medicine, China Medical University, Taichung, Taiwan
2The Pre-Clinical Medicine College, Nanjing University of Traditional Chinese Medicine, Nanjing 210029 Jiangsu, China
3Drexel University, School of Nursing and Health Professions, Department of Physical Therapy and Rehabilitation Sciences, Philadelphia, PA, USA
4School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 404, Taiwan
5Graduate Institute of Chinese Medical Science, China Medical University, Taichung 404, Taiwan
6Department of Healthcare Administration, Asia University, Taichung, Taiwan
7Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
8Emergency Department, Taichung Veterans General Hospital, Taiwan
9Orthopaedic Department, Armed Forces General Hospital, Taichung, Taiwan
10Graduate Institute of Basic Medical Science, China Medical University, Taichung 404, Taiwan
11Department of Health and Nutrition Biotechnology, Asia University, Taichung 413, Taiwan

Received 21 April 2010; Accepted 25 May 2010

Copyright © 2011 Yung-Ming Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Bunge, “Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration,” Current Opinion in Neurobiology, vol. 3, no. 5, pp. 805–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Fawcett and R. J. Keynes, “Peripheral nerve regeneration,” Annual Review of Neuroscience, vol. 13, pp. 43–60, 1990. View at Google Scholar · View at Scopus
  3. K. Torigoe, H.-F. Tanaka, A. Takahashi, A. Awaya, and K. Hashimoto, “Basic behavior of migratory Schwann cells in peripheral nerve regeneration,” Experimental Neurology, vol. 137, no. 2, pp. 301–308, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. E. S. Anton, A. W. Sandrock Jr., and W. D. Matthew, “Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vivo: evidence using an antibody to merosin, ARM-1,” Developmental Biology, vol. 164, no. 1, pp. 133–146, 1994. View at Publisher · View at Google Scholar
  5. C. Ide, “Peripheral nerve regeneration,” Neuroscience Research, vol. 25, no. 2, pp. 101–121, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. W. D. Snider, F.-Q. Zhou, J. Zhong, and A. Markus, “Signaling the pathway to regeneration,” Neuron, vol. 35, no. 1, pp. 13–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Pearson, F. Robinson, T. B. Gibson et al., “Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions,” Endocrine Reviews, vol. 22, no. 2, pp. 153–183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Meintanis, D. Thomaidou, K. R. Jessen, R. Mirsky, and R. Matsas, “The neuron-glia signal β-neuregulin promotes Schwann cell motility via the MAPK pathway,” GLIA, vol. 34, no. 1, pp. 39–51, 2001. View at Publisher · View at Google Scholar
  9. P. P. Roux and J. Blenis, “ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions,” Microbiology and Molecular Biology Reviews, vol. 68, no. 2, pp. 320–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Huang, K. Jacobson, and M. D. Schaller, “MAP kinases and cell migration,” Journal of Cell Science, vol. 117, no. 20, pp. 4619–4628, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. K. B. Reddy, S. M. Nabha, and N. Atanaskova, “Role of MAP kinase in tumor progression and invasion,” Cancer and Metastasis Reviews, vol. 22, no. 4, pp. 395–403, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Ma and R. Quirion, “The ERK/MAPK pathway, as a target for the treatment of neuropathic pain,” Expert Opinion on Therapeutic Targets, vol. 9, no. 4, pp. 699–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Wiklund, P. A. Ekstrom, and A. Edstrom, “Mitogen-activated protein kinase inhibition reveals differences in signalling pathways activated by neurotrophin-3 and other growth-stimulating conditions of adult mouse dorsal root ganglia neurons,” Journal of Neuroscience Research, vol. 67, no. 1, pp. 62–68, 2002. View at Publisher · View at Google Scholar
  14. L. B. Siconolfi and N. W. Seeds, “Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush,” Journal of Neuroscience, vol. 21, no. 12, pp. 4348–4355, 2001. View at Google Scholar · View at Scopus
  15. L. B. Siconolfi and N. W. Seeds, “Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush,” Journal of Neuroscience, vol. 21, no. 12, pp. 4336–4347, 2001. View at Google Scholar
  16. G. Murphy, S. Atkinson, R. Ward, J. Gavrilovic, and J. J. Reynolds, “The role of plasminogen activators in the regulation of connective tissue metalloproteinases,” Annals of the New York Academy of Sciences, vol. 667, pp. 1–12, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. L. B. Siconolfi and N. W. Seeds, “Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush,” Journal of Neuroscience Research, vol. 74, no. 3, pp. 430–434, 2003. View at Publisher · View at Google Scholar
  18. S. Koochekpour, O. Sartor, M. Hiraiwa et al., “Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells,” Asian Journal of Andrology, vol. 7, no. 2, pp. 147–158, 2005. View at Publisher · View at Google Scholar
  19. M. Hecht, U. Heider, M. Kaiser, I. von Metzler, J. Sterz, and O. Sezer, “Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK,” British Journal of Haematology, vol. 138, no. 4, pp. 446–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Schumacher, I. Jung-Testas, P. Robel, and E. E. Baulieu, “Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP,” Glia, vol. 8, no. 4, pp. 232–240, 1993. View at Google Scholar · View at Scopus
  21. D. Le Roith and A. A. Butler, “Insulin-like growth factors in pediatric health and disease,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 12, pp. 4355–4361, 1999. View at Google Scholar · View at Scopus
  22. E. DiCicco-Bloom and I. B. Black, “Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 11, pp. 4066–4070, 1988. View at Google Scholar
  23. Y. Aizenman and J. de Vellis, “Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation,” Brain Research, vol. 406, no. 1-2, pp. 32–42, 1987. View at Google Scholar
  24. P. Caroni and P. Grandes, “Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors,” Journal of Cell Biology, vol. 110, no. 4, pp. 1307–1317, 1990. View at Google Scholar · View at Scopus
  25. C. L. Delaney, H.-L. Cheng, and E. L. Feldman, “Insulin-like growth factor-I prevents caspasemediated apoptosis in Schwann cells,” Journal of Neurobiology, vol. 41, no. 4, pp. 540–548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Koriyama, K. Homma, K. Sugitani et al., “Upregulation of IGF-I in the goldfish retinal ganglion cells during the early stage of optic nerve regeneration,” Neurochemistry International, vol. 50, no. 5, pp. 749–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. I. Jones and D. R. Clemmons, “Insulin-like growth factors and their binding proteins: biological actions,” Endocrine Reviews, vol. 16, no. 1, pp. 3–34, 1995. View at Google Scholar · View at Scopus
  28. G. Mairet-Coello, A. Tury, and E. DiCicco-Bloom, “Insulin-like growth factor-1 promotes G1/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex,” Journal of Neuroscience, vol. 29, no. 3, pp. 775–788, 2009. View at Publisher · View at Google Scholar
  29. G. M. Leinninger, C. Backus, M. D. Uhler, S. I. Lentz, and E. L. Feldman, “Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons,” FASEB Journal, vol. 18, no. 13, pp. 1544–1546, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. W. M. Campana, S. J. Darin, and J. S. O'Brien, “Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells,” Journal of Neuroscience Research, vol. 57, no. 3, pp. 332–341, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Maurel and J. L. Salzer, “Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity,” Journal of Neuroscience, vol. 20, no. 12, pp. 4635–4645, 2000. View at Google Scholar · View at Scopus
  32. K. A. Sullivan, B. Kim, and E. L. Feldman, “Insulin-like growth factors in the peripheral nervous system,” Endocrinology, vol. 149, no. 12, pp. 5963–5971, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Vincent, B. C. Mobley, A. Hiller, and E. L. Feldman, “IGF-I prevents glutamate-induced motor neuron programmed cell death,” Neurobiology of Disease, vol. 16, no. 2, pp. 407–416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-C. Tsai, M.-C. Lu, Y.-S. Chen, C.-H. Wu, and C.-C. Lin, “Locally administered nerve growth factor suppresses ginsenoside Rb 1-enhanced peripheral nerve regeneration,” American Journal of Chinese Medicine, vol. 31, no. 5, pp. 665–673, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. E. L. Cooper, B. Ru, and N. Weng, “Earthworms: sources of antimicrobial and anticancer molecules,” Advances in Experimental Medicine and Biology, vol. 546, pp. 359–389, 2004. View at Google Scholar · View at Scopus
  36. E. L. Cooper, “Complementary and alternative medicine, when Rigorous, can be science,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 1–4, 2004. View at Google Scholar
  37. L. S. Ranganathan, Vermibiotechnology: From Soil Health to Human Health, Agrobios, 2006.
  38. C. L. Hsieh, T. H. Liu, J. G. Lin et al., “The relationship between Bu-Yang-Huan-Wu-Tang improve cerebral infarct and regulation of Nitric oxide in ischemia-reperfusion rats,” Taiwanese Journal of Chinese Medicine, vol. 3, pp. 20–35, 2004. View at Google Scholar
  39. X. L. Wang, “Experimental research on Bu Yang Huan Wu Tang's effect on peripheral nerve regeneration,” Journal of Shandong Medical University, vol. 37, pp. 41–43, 1999. View at Google Scholar
  40. Y. Y. Dong, “Experimental research on modified Bu Yang Huan Wu Tang to treat spinal cord injuries in rats,” China Journal of Zheng Gu, vol. 10, pp. 3–4, 1998. View at Google Scholar
  41. E. L. Cooper, “CAM, eCAM, bioprospecting: the 21st century pyramid,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 2, pp. 125–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Balamurugan, K. Parthasarathi, L. S. Ranganathan, and E. L. Cooper, “Hypothetical mode of action of earthworm extract with hepatoprotective and antioxidant properties,” Journal of Zhejiang University: Science B, vol. 9, no. 2, pp. 141–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Zhang, X. Li, Y. Liu, F. Ye, and G. Qiu, “Effects of extract of Dilong (Pheretima) on the scalded skin in rats,” Journal of Traditional Chinese Medicine, vol. 26, no. 1, pp. 68–71, 2006. View at Google Scholar · View at Scopus
  44. H. Mihara, M. Maruyama, and H. Sumi, “Novel thrombolytic therapy discovered from traditional oriental medicine using the earthworm,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 23, supplement 2, pp. 131–140, 1992. View at Google Scholar · View at Scopus
  45. S. Wei, P. Zhang, Y. Dang, H. Zhang, and B. Jiang, “Primary study on effect of various components of modified formula radix hedysari on peripheral nerve regeneration,” Zhongguo Xiufu Chongjian Waike Zazhi, vol. 22, no. 9, pp. 1056–1059, 2008. View at Google Scholar · View at Scopus
  46. S. Matsuba, “Complementary and alternative approaches to biomedicine,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 345–348, 2004. View at Google Scholar
  47. W. Hu and T. Fu, “Isolation and properties of a novel fibrinolytic enzyme from an earth worm,” Zhong Yao Cai, vol. 20, no. 2, pp. 78–81, 1997. View at Google Scholar · View at Scopus
  48. E. L. Cooper, T. M. Hrzenjak, and M. Grdiša, “Alternative sources of fibrinolytic, anticoagulative, antimicrobial and anticancer molecules,” International Journal of Immunopathology and Pharmacology, vol. 17, no. 3, pp. 237–244, 2004. View at Google Scholar · View at Scopus
  49. J. Witowsky, A. Abell, N. L. Johnson, G. L. Johnson, and B. D. Cuevas, “MEKK1 is required for inducible urokinase-type plasminogen activator expression,” Journal of Biological Chemistry, vol. 278, no. 8, pp. 5941–5946, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Yu, D. Bian, C. Mahanivong, R. K. Cheng, W. Zhou, and S. Huang, “P38 mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression,” Journal of Biological Chemistry, vol. 279, no. 48, pp. 50446–50454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. M. Chang, Y. T. Shih, Y. S. Chen et al., “Schwann cell migration induced by dilong extract via activation of PAs and MMP2/9 mediated through ERK1/2 and p38,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  52. R. N. Pittman and A. J. DiBenedetto, “PC12 cells overexpressing tissue plasminogen activator regenerate neurites to a greater extent and migrate faster than control cells in complex extracellular matrix,” Journal of Neurochemistry, vol. 64, no. 2, pp. 566–575, 1995. View at Google Scholar · View at Scopus
  53. E. Ulfhammer, P. Larsson, L. Karlsson et al., “TNF-α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-κB- and p38 MAPK-dependent,” Journal of Thrombosis and Haemostasis, vol. 4, no. 8, pp. 1781–1789, 2006. View at Publisher · View at Google Scholar
  54. C.-L. Hu, R. G. Cowan, R. M. Harman, and S. M. Quirk, “Cell cycle progression and activation of Akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells,” Molecular Endocrinology, vol. 18, no. 2, pp. 326–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Homma, Y. Koriyama, K. Mawatari, Y. Higuchi, J. Kosaka, and S. Kato, “Early downregulation of IGF-I decides the fate of rat retinal ganglion cells after optic nerve injury,” Neurochemistry International, vol. 50, no. 5, pp. 741–748, 2007. View at Publisher · View at Google Scholar
  56. C. L. Delaney, H.-L. Cheng, and E. L. Feldman, “Insulin-like growth factor-I prevents caspasemediated apoptosis in Schwann cells,” Journal of Neurobiology, vol. 41, no. 4, pp. 540–548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. K. D. Beck, L. Powell-Braxton, H.-R. Widmer, J. Valverde, and F. Hefti, “Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons,” Neuron, vol. 14, no. 4, pp. 717–730, 1995. View at Google Scholar · View at Scopus
  58. C. M. Cheng, G. Joncas, R. R. Reinhardt et al., “Biochemicaland morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition,” Journal of Neuroscience, vol. 18, pp. 5673–5681, 1998. View at Google Scholar
  59. M. A. Stull, A. M. Rowzee, A. V. Loladze, and T. L. Wood, “Growth factor regulation of cell cycle progression in mammary epithelial cells,” Journal of Mammary Gland Biology and Neoplasia, vol. 9, no. 1, pp. 15–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. M. Chang, W. H. Kuo, T. Y. Lai et al., “RSC96 Schwann cell proliferation and survival induced by dilong extract through PI3K/Akt signaling mediated by IGF-I,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  61. T. Hrzenjak, M. Hrzenjak, V. Kasuba, P. Efenberger-Marinculic, and S. Levana, “A new source of biologically active compounds—earthworm tissue (Eisenia foetida, Lumbricus rubelus),” Comparative Biochemistry and Physiology A, vol. 102, no. 3, pp. 441–447, 1992. View at Publisher · View at Google Scholar · View at Scopus
  62. V. Ann Flørenes, G. Mari Mælandsmo, R. Faye, J. M. Nesland, and R. Holm, “Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome,” Journal of Pathology, vol. 195, no. 5, pp. 530–536, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. D. H. Walker and J. L. Maller, “Role for cyclin A in the dependence of mitosis on completion of DNA replication,” Nature, vol. 354, no. 6351, pp. 314–317, 1991. View at Publisher · View at Google Scholar · View at Scopus
  64. D. R. Clemmons, J. J. van Wyk, and W. J. Pledger, “Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, pp. 6644–6648, 1980. View at Google Scholar
  65. N. E. Olashaw, J. J. van Wyk, and W. J. Pledger, “Control of late G0/G1 progression and protein modification by SmC/IGF I,” American Journal of Physiology, vol. 253, no. 4, pp. C575–C579, 1987. View at Google Scholar · View at Scopus
  66. M. A. Stull, M. M. Richert, A. V. Loladze, and T. L. Wood, “Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells,” Endocrinology, vol. 143, no. 5, pp. 1872–1879, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Tang, D. Liang, T. Jiang, J. Zhang, L. Gui, and W. Chang, “Crystal structure of earthworm fibrinolytic enzyme component A: revealing the structural determinants of its dual fibrinolytic activity,” Journal of Molecular Biology, vol. 321, no. 1, pp. 57–68, 2002. View at Publisher · View at Google Scholar
  68. J. Zhao, R. Pan, J. He, Y. Liu, D.-F. Li, and R.-Q. He, “Eisenia fetida protease-III-1 functions in both fibrinolysis and fibrogenesis,” Journal of Biomedicine and Biotechnology, vol. 2007, Article ID 97654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Muir, “Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor,” Experimental Cell Research, vol. 210, no. 2, pp. 243–252, 1994. View at Publisher · View at Google Scholar · View at Scopus
  70. E. M. Muir, K. H. Adcock, D. A. Morgenstern et al., “Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes,” Molecular Brain Research, vol. 100, no. 1-2, pp. 103–117, 2002. View at Publisher · View at Google Scholar
  71. H. Nagase, “Activation mechanisms of matrix metalloproteinases,” Biological Chemistry, vol. 378, no. 3-4, pp. 151–160, 1997. View at Google Scholar · View at Scopus
  72. M. Hrzenjak, D. Kobrehel, S. Levanat, M. Jurin, and T. Hrzenjak, “Mitogenicity of the earthworm's (Eisenia foetida) insulin-like proteins,” Comparative Biochemistry and Physiology B, vol. 104, no. 4, pp. 723–729, 1993. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Grdisa, M. Popovic, and T. Hrzenjak, “Glycolipoprotein extract (G-90) from earthworm Eisenia foetida exerts some antioxidative activity,” Comparative Biochemistry and Physiology A, vol. 128, no. 4, pp. 821–825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Hrženjak, M. Popović, T. Božić, M. Grdisa, D. Kobrehel, and L. Tiška-Rudman, “Fibrinolytic and anticoagulative activities from the earthworm Eisenia foetida,” Comparative Biochemistry and Physiology B, vol. 119, no. 4, pp. 825–832, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. T. M. Hrženjak, M. Popović, and L. Tiška-Rudman, “Fibrinolytic activity of earthworms extract (G-90) on lysis of fibrin clots originated from the venous blood of patients with malignant tumors,” Pathology and Oncology Research, vol. 4, no. 3, pp. 206–211, 1998. View at Google Scholar
  76. M. Grdiša, M. Popović, and T. Hrženjak, “Stimulation of growth factor synthesis in skin wounds using tissue extract (G-90) from the earthworm Eissenia foetida,” Cell Biochemistry and Function, vol. 22, no. 6, pp. 373–378, 2004. View at Publisher · View at Google Scholar
  77. K. Kolkova, V. Novitskaya, N. Pedersen, V. Berezin, and E. Bock, “Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway,” Journal of Neuroscience, vol. 20, no. 6, pp. 2238–2246, 2000. View at Google Scholar
  78. S. Diestel, C. L. Hinkle, B. Schmitz, and P. F. Maness, “NCAM140 stimulates integrin-dependent cell migration by ectodomain shedding,” Journal of Neurochemistry, vol. 95, no. 6, pp. 1777–1784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. G. T. Williams, C. A. Smith, E. Spooncer, T. M. Dexter, and D. R. Taylor, “Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis,” Nature, vol. 343, no. 6253, pp. 76–79, 1990. View at Publisher · View at Google Scholar · View at Scopus
  80. S. R. Datta, H. Dudek, T. Xu et al., “Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery,” Cell, vol. 91, no. 2, pp. 231–241, 1997. View at Publisher · View at Google Scholar · View at Scopus
  81. J. G. Boyd and T. Gordon, “A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor,” European Journal of Neuroscience, vol. 15, no. 4, pp. 613–626, 2002. View at Publisher · View at Google Scholar · View at Scopus